R&D Trends

Russia approves 95 new clinical trials in first quarter

Monday, June 6, 2011 03:02 PM

The Ministry of Health and Social Development of the Russian Federation (MoH) approved 95 new clinical trials of all types including local studies during the first quarter of 2011, 29% less than the year-ago quarter, according to a quarterly analytical report produced by Moscow-based CRO Synergy Research Group (SynRG).

More... »

Drug discovery industry in midst of 'profound change'

Thursday, June 2, 2011 12:50 PM

Drug makers are "defining a new contract with society" as they overhaul their R&D, according to the former head of the sector's trade body.

More... »

Oncology drug development investment remains strong

Thursday, June 2, 2011 12:39 PM

Investment in oncology drug development remains strong, as 133 companies initiated late-stage clinical trials from October 2009 to September 2010, a 21% increase, according to Citeline, a research company focusing on pharmaceutical clinical trials and intelligence.

More... »

North American pharma growing by overseas acquisitions

Tuesday, May 31, 2011 03:24 PM

European drugmakers have more competition for nearby buyouts these days, according to a report on FiercePharma. With North America's pharma companies turning to international markets for growth, they're scouting Central Europe, Eastern Europe, Turkey and the Middle East for potential generics deals, which is likely to push prices upward, experts told Dow Jones.

More... »

U.S. R&D productivity often undercounted, as most reports omit FDA biologics approvals

Tuesday, May 31, 2011 09:44 AM

Most reports of pharmaceutical R&D productivity undercount the number of new drugs that reach the market each year, missing out on billions of dollars of sales, because they omit approvals from the Food and Drug Administration’s (FDA) biologics division, according to a new report by London-based research company EvaluatePharma.

More... »

Hot jobs in life sciences will be in systems biology, bioinformatics

Wednesday, May 25, 2011 12:44 PM

“Unprecedented opportunity” exists for job seekers in systems biology and bioinformatics, which seek not only biologists, but also engineers, chemists, mathematicians and computer programmers, according to Bernhard Palsson of the University of California, San Diego.

More... »

Pharmascience is expanding and adding new jobs

Tuesday, May 17, 2011 12:36 PM

Canada-based Pharmascience is opening up new R&D labs and offices in Montreal and expects to hire an additional 180 workers.

More... »

Nearly 900 new drugs in R&D for diseases affecting women

Tuesday, May 17, 2011 11:37 AM

A new industry report published by U.S. drugmakers states that almost 900 medicines are in development for diseases specifically affecting women, according to Pharma Times.

More... »

Quintiles collaborates with PGT

Tuesday, May 17, 2011 11:32 AM

Quintiles has partnered with Population Genetics Technologies (PGT), a U.K.-based company that specializes in large-scale, lower-cost genomic analyses, according to PharmaTimes.

More... »

GVK partners with Gates Foundation

Monday, May 16, 2011 12:44 PM

India-based CRO GVK Biosciences has been named as a preferred provider by a consortium, Product Development Partners (PDP), which is focused on drugs for neglected diseases.

More... »